EA201270786A1 - α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА - Google Patents

α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА

Info

Publication number
EA201270786A1
EA201270786A1 EA201270786A EA201270786A EA201270786A1 EA 201270786 A1 EA201270786 A1 EA 201270786A1 EA 201270786 A EA201270786 A EA 201270786A EA 201270786 A EA201270786 A EA 201270786A EA 201270786 A1 EA201270786 A1 EA 201270786A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carbabenzpyrid
crystal form
carbabenzopyrid
relates
crystalline form
Prior art date
Application number
EA201270786A
Other languages
English (en)
Other versions
EA019080B1 (ru
EA019080B9 (ru
Inventor
Филя Жебровска
Виктор Маргитич
Григорий Костюк
Олег Сяркевич
Михайло Ванат
Original Assignee
Фармак Интернэшнл Холдинг Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармак Интернэшнл Холдинг Гмбх filed Critical Фармак Интернэшнл Холдинг Гмбх
Publication of EA201270786A1 publication Critical patent/EA201270786A1/ru
Publication of EA019080B1 publication Critical patent/EA019080B1/ru
Publication of EA019080B9 publication Critical patent/EA019080B9/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)

Abstract

Настоящее изобретение относится к новой кристаллической форме карбабензпирида формулы (I)и способу ее получения. Также изобретение касается применения новой кристаллической формы карбабензпирида для лечения и предупреждения вирусных инфекций.
EA201270786A 2010-06-17 2011-06-15 α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА EA019080B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2010/001956 WO2011158058A1 (en) 2010-06-17 2010-06-17 α-CRYSTALLINE FORM OF CARBABENZPYRIDE
PCT/EP2011/059922 WO2011157743A1 (en) 2010-06-17 2011-06-15 Alpha-crystalline form of carbabenzpyride

Publications (3)

Publication Number Publication Date
EA201270786A1 true EA201270786A1 (ru) 2013-02-28
EA019080B1 EA019080B1 (ru) 2013-12-30
EA019080B9 EA019080B9 (ru) 2014-03-31

Family

ID=43607637

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270786A EA019080B9 (ru) 2010-06-17 2011-06-15 α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА

Country Status (7)

Country Link
US (1) US8404857B2 (ru)
EP (1) EP2513060B1 (ru)
CA (1) CA2790294C (ru)
EA (1) EA019080B9 (ru)
PL (1) PL2513060T3 (ru)
UA (1) UA104102C2 (ru)
WO (2) WO2011158058A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170901A1 (en) * 2012-05-18 2013-11-21 Farmak International Holding Gmbh N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
EA201792455A1 (ru) * 2017-12-06 2019-06-28 Открытое акционерное общество "Авексима" Нобазит кристаллический в форме ромбической сингонии и способ его получения
RU2689775C1 (ru) * 2018-11-02 2019-05-29 Открытое акционерное общество "Авексима" Способ промышленного производства N-метил-4-бензилкарбамидопиридиния йодида

Also Published As

Publication number Publication date
EA019080B1 (ru) 2013-12-30
US8404857B2 (en) 2013-03-26
EP2513060B1 (en) 2013-09-11
CA2790294A1 (en) 2011-12-22
WO2011158058A1 (en) 2011-12-22
CA2790294C (en) 2013-05-28
EA019080B9 (ru) 2014-03-31
EP2513060A1 (en) 2012-10-24
UA104102C2 (en) 2013-12-25
US20120309978A1 (en) 2012-12-06
PL2513060T3 (pl) 2014-02-28
WO2011157743A1 (en) 2011-12-22

Similar Documents

Publication Publication Date Title
EA201290632A1 (ru) Производные бетулина
EA201301320A1 (ru) 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу
EA201490724A1 (ru) Замещенные соединения тетрагидроизохинолина в качестве ингибиторов фактора xia
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
MD20140136A2 (ru) Ингибиторы вируса гепатита С
EA201490474A1 (ru) Аминохиназолины в качестве ингибиторов киназ
EA201390576A1 (ru) Противовирусные соединения
UA111841C2 (uk) Сполуки бензотіазолу та їх фармацевтичне застосування
IN2014MN02652A (ru)
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201101026A1 (ru) Ингибиторы бета-секретазы
EA201591527A1 (ru) Новые производные пиридина
EA201590890A1 (ru) Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу
EA201490854A1 (ru) Противовирусные соединения
EA201270149A1 (ru) Ингибиторы bace
EA201300604A1 (ru) Соединения, предназначенные для лечения респираторно-синцитиальных вирусных инфекций
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
EA201300388A1 (ru) Соединения замещенного бензамида
AU2011286276A8 (en) Substituted Biphenylene Compounds and methods of use thereof for the treatment of viral diseases
EA201490650A1 (ru) Фармацевтические композиции
EA201190293A1 (ru) Пролекарства триптолида
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
IN2014CN04449A (ru)
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM TJ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ KG MD TM RU